Actively Recruiting
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Led by University of Pittsburgh · Updated on 2025-11-12
2000
Participants Needed
1
Research Sites
1695 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
CONDITIONS
Official Title
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Diagnosis of pulmonary fibrosis confirmed by physical examination, pulmonary function testing, chest X-ray, and computed tomography (CT) scans
- Adult patients who are seeking treatment at the Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease
You will not qualify if you...
- Under 18 years of age
- Non-fibrotic interstitial lung disease (ILD)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
M
Michelle F MacPherson, MAT
CONTACT
M
Michelle Meyers, BSN
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here